Search Results 1641-1650 of 17623 for Absence

  1. Cardiovascular Medicine - Clinical trials

    All offspring will undergo postnatal genetic testing for the parental mutation as the gold standard for diagnosing the presence or absence of LQTS.

  2. Publications - Paul J. Jannetto, Ph.D. - Mayo Clinic

    Fecal electrolyte testing for evaluation of unexplained diarrhea: Validation of body fluid test accuracy in the absence of a reference method. Clin Biochem ...

  3. Trevogrumab or Trevogrumab with Garetosmab when taken with Semaglutide in patients with obesity. - Mayo Clinic

    However, in the absence of 12 months of amenorrhea, a single FSH measurement is insufficient to determine the occurrence of a postmenopausal state. The ...

  4. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    Alkaline phosphatase (ALP) (in the absence of bone disease), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) ≤3 × ULN (≤5 × ULN if ...

  5. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    Any number of biologic therapies (e.g., bevacizumab) or immunotherapies is allowed in the absence of co-administered chemotherapy and must have been ...

  6. Pediatrics Clinical Trials - Medical Professionals

    All offspring will undergo postnatal genetic testing for the parental mutation as the gold standard for diagnosing the presence or absence of LQTS. Hearing ...

  7. Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers - Mayo Clinic

    - Absence of proteinuria at screening as demonstrated by one of the following (obtained =< 14 days prior to registration): - Urine protein/creatinine (UPC) ...

  8. Hematology - Clinical trials

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  9. Neurosurgery - Clinical trials

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  10. Publications - Michelle A. Anderson, M.D. - Mayo Clinic

    ... Absence of Overt Chronic Pancreatitis. Am J Gastroenterol. 2018 Jun; 113 (6):906-912 Epub 2018 June 05. View PubMed; Kurlander JE, Barnes GD, Anderson MA ...